Ann Arbor, MI, United States of America

David B Capps


Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1980-1986

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David B Capps

Introduction

David B Capps is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial and antitumor agents. With a total of six patents to his name, Capps has demonstrated a commitment to advancing medical science through his innovative work.

Latest Patents

Capps' latest patents include "Substituted 1-amino-4-nitro-acridinones and methods of treating" and "Method of treating leukemia with pyrazolo[3,4,5-kl]acridines." The first patent describes substituted 1-amino-4-nitroacridinones, their method of manufacture, pharmaceutical compositions, and their use as antibacterial and antitumor agents. The second patent focuses on pyrazolo[3,4,5-kl]acridines, which are also described as antibacterial and antitumor agents, along with methods for their preparation.

Career Highlights

Capps has worked at Warner-Lambert Company, where he has been able to apply his expertise in pharmaceutical innovation. His work has contributed to the development of new treatments that have the potential to improve patient outcomes in various medical conditions.

Collaborations

Capps has collaborated with notable colleagues such as Edward Faith Elslager and Leslie M Werbel. These collaborations have likely enhanced the scope and impact of his research and inventions.

Conclusion

David B Capps is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in antibacterial and antitumor treatments. His contributions continue to influence the field and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…